Dr. Sherry McAllister, Executive Vice President for the Foundation for Chiropractic Progress, discusses the realities of pain management and opioid addiction as well as drug-free pain management options such as chiropractic. Chiropractic celebrated it’s 123rd birthday in the U.S. on September 18, 2018.
Patients who are seeking for a particular healthcare service don’t always go for the cheapest option. Some patients from just across town or around the country are willing to travel for the quality, affordable care they seek. In this interview with Dr. Myles Holt, he talks about an online healthcare platform called TENDER and explains how it changes the way patients communicate with providers by obtaining second opinions, treatment options and fee estimate online.
Ken Cahill, CEO of SilverCloud Health, discusses the care gap in treating mental illness worldwide, pointing specifically to regions like the UK and US, and what can be done to close this gap. Silver Cloud offers support programs for a range of mental and behavioral health issues.
Dr. George Grunberger shares the results of the national Type 1 Diabetes (T1D) Unmet Needs Survey that was commissioned by The American Association of Clinical Endocrinologists (AACE), to examine the support, management and treatment of the disease and why it is important to continue prioritizing and advancing innovation to help people achieve better outcomes.
Joel Tune, CEO of Enteris Biopharma, discusses their proprietary drug delivery technology (Peptelligence®) that allows medicines to be delivered orally versus injection. The technology has been developed and proven effective to enable the safe delivery of peptide-based therapeutics and other molecules with low oral bioavailability.
Steve Parkinson, President and CEO of Lakewood-Amedex (a privately-held, clinical stage pharmaceutical company), discusses their development of a broad portfolio of first-in-class antimicrobial and antifungal therapeutics called bisphosphocins™
Colette Courtion, Joylux Founder and CEO discusses vFit, a device designated as a Low-Risk General Wellness Product by the FDA, that is the world’s first non-invasive, hormone-free intimate wellness solution incorporating a patented combination of red light (LED), gentle heat, and sonic technology for use at home. For more information, you may visit www.getvfit.com.
Dr. Ellen Manos, a Doctor Advocate for JDS Therapeutics, discusses a dedicated line of natural, plant-based, nutraceutical products for non-hormonal treatment of PMS, perimenopause, and menopause, what women can expect, and what advancements are being introduced in the field.
CEO of On Target Laboratories, Martin Low, discusses On Target’s development of two new drugs: OTL78, for the treatment of prostate cancer that selectively finds, infiltrates and identifies cancer cells, even those hidden below healthy tissue; and On Target’s lead candidate, OTL38, that operates very similarly to OTL78.
Dr. Bruce Levy, a Mayo Clinic orthopedic and sports medicine surgeon, and his wife Heather Levy have developed the first and only medical-grade privacy garment available that fully covers the genital area, allows procedural access, and meets strict FDA guidelines for use in the operating room and other healthcare settings. Dr. Levy discusses the issue of patient privacy and shares more about COVR Medical garments as well as tips to ensure patients feel comfortable.